AstraZeneca announced a strategic joint venture with the Chinese Future Industry Investment Fund (FIIF) to form an equally-owned, stand-alone company...
Read more
Exelixis has announced that the phase 3 CELESTIAL trial results have been accepted as a late-breaking presentation at the 2018...
Read more
BiondVax Pharmaceuticals Ltd. has announced the signing of the clinical trial agreement (CTA) for a phase 2 clinical trial with...
Read more
At the 5th Canton Nucleic Acids Forum (CNAF) in Guangzhou, China, Guangzhou RiboBio Co., Ltd. ("RiboBio") and GE Healthcare Life...
Read more
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, and Macroceutics, Inc., today...
Read more
Roche has announced that the phase III IMpower150 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that...
Read more
Chugai Pharmaceutical has announced that the primary endpoint has been met for the global phase III HAVEN 3 (NCT02847637) study...
Read more
Adocia a clinical stage biopharmaceutical company focused on diabetes treatment with innovative formulations of approved proteins, announced top-line results of...
Read more
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray...
Read more
Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced that it has commenced a...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
